Da Vinci SP Robotic Surgery for Cervical Cancer FIGO 2018 Stage IA-IB: A Pilot Study

Abstract

Abstract Da Vinci SP robotic platform is utilized in benign gynecology, with no study of its use for cervical cancer surgery till date. The study aimed to present clinical experience and surgical outcome of da Vinci SP robotic surgery for cervical cancer stage IA-IB. This cross-sectional study involved patients undergoing da Vinci SP robotic type B radical hysterectomy (RH), type C1 RH, and radical trachelectomy (RT) from January 2019 until December 2021. Median age and body mass index were 38 years old (28–49) and 21.6 kg/m2 (17.6–33.6) respectively. 61.5% were stage IA1, 23.1% IB1 and 15.4% IB2. 6 underwent type B RH, 1 type C RH, and 6 RT. Median docking time, console time and total operation time were 4 minutes (2–9), 151 minutes (75–258) and 278 minutes (159–360) respectively. Median estimated blood loss was 50 mL (10–100). Median pain score was 3, 0, 0, and 0 at 0-, 6-, 12-, and 24-hour post-surgery. Median postoperative hospital stay was 2 days (2–4). In conclusion, da Vinci SP robotic surgery for cervical cancer stage IA-IB could be performed with good peri-operative surgical outcomes. Large scaled long-term follow-up studies are required to assess oncological outcomes of patients undergoing these procedures.